Goldline Pharmaceutical Ltd. Chart Analysis Subscription 598.7× Profit & Loss Ratios Objects Dates Lot Size Allotment

Goldline Pharmaceutical Ltd.

·
₹43.00 Issue Price
2026-05-12 – 2026-05-14
www.goldlinepharma.in Bookbuilding IPO · BSE SME
Open Date
2026-05-12
Close Date
2026-05-14
Listing Date
2026-05-19
Allotment Date
2026-05-15
Current Price
₹43.00
High / Low
₹— / ₹—
ROCE
38.46 %
ROE
35.84 %
Face Value
₹10
Add ratio to table Edit ratios
About
Goldline Pharmaceuticals is engaged in the business of marketing pharmaceutical products under the brand name “Goldline.” Its product range is divided into five segments:Goldline Pharma: This category includes 42 product…
📍 103, F-1, Leela Apartment, Shilpa HSG Society, Near Saptagiri Nagar, Shanidham, …
📞 +91 712 2786666
✉️ info@goldlinepharma.in
₹43.00 Issue Price
📊
Loading chart…

Analysis

Pros

  • ROE of 35.84% indicates good return on equity.
  • ROCE of 38.46% shows efficient capital usage.
  • PAT margin of 10.10%.

Cons

  • Debt/equity of 1.50x may be high.

Pros and cons are machine generated. Please exercise caution and do your own analysis.

Subscription Status

Consolidated figures
598.69× overall
Day 1
0.00×
Day 2
0.00×
Day 3
0.00×
MetricQIBNII (HNI)RetailTotal
Subscription 76.99× 1,664.45× 874.20× 598.69×
Shares 12,72,000 3,90,000 9,00,000 25,62,000
Bids 9,79,29,000 64,91,34,000 78,67,80,000 1,53,38,43,000
▼ Category-wise Detailed Breakdown
CategorySubscriptionOffered Bid SharesAmt (₹ Cr)
QIB 76.99×
12,72,000 9,79,29,000 ₹421.09
NII (HNI) 1,664.45×
3,90,000 64,91,34,000 ₹2,791.28
Retail 874.20×
9,00,000 78,67,80,000 ₹3,383.15
Market Maker 1.00×
1,38,000 1,38,000 ₹0.59
Total 598.69× 25,62,000 1,53,38,43,000 ₹6,596.11 Cr
Applications: - Total Bid Amount: ₹6,596.11 Cr

Profit & Loss

Figures in ₹ Crores / Amount in ₹ Crore
Metric 31 Mar 202531 Mar 202431 Mar 2023
Revenue 28.06 23.57 19.85
EBITDA 5.83 4.30 2.19
Profit After Tax 2.83 1.81 0.26
Net Worth 10.35 7.87 5.89
Total Assets 26.28 22.93 19.39
Reserves 1.65 3.76 2.08
Borrowings 11.03 11.13 10.83
Sales Growth
3 Years:-29.3%
Latest:19.85 Cr
Profit Growth
3 Years:-90.8%
Latest PAT:0.26 Cr
Return on Equity
ROE:35.84%
ROCE:38.46%

Key Financial Ratios

Profitability
ROE 35.84%
ROCE 38.46%
RONW 27.38%
PAT Margin 10.10%
EBITDA Margin 20.79%
Valuation
Leverage & Growth
Debt / Equity 1.50×
Sales Growth (3yr) -29.3%
Profit Growth (3yr) -90.8%
Latest Revenue 19.85 Cr
Latest PAT 0.26 Cr

Objects of the Issue

1 Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our company ₹8.90 Cr
2 General corporate purposes

IPO Schedule & Important Dates

IPO Open
2026-05-12
Done ✓
IPO Close
2026-05-14
Done ✓
Allotment
2026-05-15
Done ✓
Refund
2026-05-18
Done ✓
Demat Credit
2026-05-18
Done ✓
Listing
2026-05-19
Today ←

Lot Size & Investment Details

RETAIL MIN
₹129,000
1 lot · 3000 shares
RETAIL MAX
₹258,000
2 lots · 6,000 shares
HNI MIN
₹387,000
3 lots
Category Lots Shares Amount (₹)
Retail (Min) 3000 3,000 ₹129,000
Retail (Max) 2 6,000 ₹258,000
HNI (Min) 3 9,000 ₹387,000
Pre-Issue Holding: 69,00,000 shares Post-Issue Holding: 96,00,000 shares

Lead Managers & Market Makers

Book Running Lead Managers
Cumulative Capital Pvt.Ltd

Allotment Status

Allotment Date: 2026-05-15
Registrar: Bigshare Services Pvt.Ltd
Check Allotment
+91-22-6263 8200
ipo@bigshareonline.com
https://ipo.bigshareonline.com/IPO_Status.html